Dr. Ally Olotu is the Chief Executive Director (CED) of the Ifakara Health Institute, effective 1 September 2026. He leads the Institute at a significant point in its nearly seven-decade history, as Ifakara continues to advance health research, develop innovative solutions, strengthen research capacity, and generate evidence that informs health policy and practice in Tanzania, Africa, and globally.

Dr. Olotu is a medical doctor and health research leader with more than 18 years of experience in infectious-disease epidemiology, immunology, vaccine development, and clinical trials. He holds a Doctor of Medicine degree from the University of Dar es Salaam and a Doctor of Philosophy degree from the University of Oxford.

His career has been marked by extensive experience in leading major clinical research programmes, including multi-country clinical trials, building international research collaborations, strengthening research platforms, and supporting the translation of scientific evidence into policy and practice. His research has focused particularly on malaria and vaccine development, while also contributing to research on other infectious and emerging diseases.

Leadership at Ifakara

Dr. Olotu brings to the CED position a strong record of scientific and institutional leadership, as well as an in-depth understanding of Ifakara's mission, people, partners, and the communities it serves.

Before his appointment as CED, he held several senior leadership positions at Ifakara, including Director of Science and Head of the Department of Biomedical Research and Clinical Trials. In these roles, he provided strategic scientific leadership, contributed to the development of institutional research priorities, strengthened partnerships, and oversaw major research programmes and clinical-trial platforms.

His previous leadership at Ifakara has positioned him to build on the Institute's established scientific strengths while advancing its ambition to deliver research and innovation with meaningful health impact.

International research experience

Before joining Ifakara, Dr. Olotu spent nine years at the KEMRI-Wellcome Trust Research Programme in Kenya, where he contributed to major studies in malaria epidemiology and vaccine development.

Throughout his career, he has worked across research, clinical trials, partnerships, and capacity strengthening, gaining extensive experience in both national and international research environments.

Fellowships and awards

Dr. Olotu is the recipient of several prestigious fellowships and awards, including the: European and Developing Countries Clinical Trials Partnership (EDCTP) Senior Fellowship; Medical Research Council (MRC) African Research Leadership Award; and the WHO/TDR Career Development Fellowship

These recognitions reflect his contribution to strengthening African research leadership and advancing scientific capacity in infectious diseases and clinical research.

Leading Ifakara into its next chapter

Dr. Olotu succeeds Dr. Honorati Masanja, who served as Chief Executive Director from 2016 to 2026 and provided a decade of dedicated leadership that strengthened Ifakara's scientific excellence, expanded its research portfolio and partnerships, and reinforced its position as one of Africa's leading health research institutions.

As Chief Executive Director, Dr. Olotu leads Ifakara into its next chapter, building on this strong foundation while championing scientific excellence, innovation, partnerships, research capacity, and impact.

With his combination of scientific expertise, institutional experience, international research leadership, and deep familiarity with Ifakara, Dr. Olotu is positioned to guide the Institute in advancing its mission to generate and translate health research evidence for better health and development.. 

His complete list of published work can be accessed here: https://www.ncbi.nlm.nih.gov/pubmed?term=Olotu%27%20Ally.